Introduction Alzheimer's disease and related dementias (ADRD) disproportionately impact
racial and ethnic minority and socioeconomically disadvantaged adults. Yet, these …

Introduction To generalize safety and efficacy findings, it is essential that diverse populations
are well represented in Alzheimer's disease (AD) drug trials. In this review, we aimed to …

Abstract Purpose of Review Acceleration of biological processes of aging is hypothesized to
drive excess morbidity and mortality in socially disadvantaged populations. DNA methylation …

Importance Representative enrollment in clinical trials is critical to ensure equitable and
effective translation of research to practice, yet disparities in clinical trial enrollment persist …

Research participants often do not represent the general population. Systematic exclusion of
particular groups from research limits the generalizability of research findings and …

Although the number of countries participating in pivotal trials submitted to enable drug
registration has nearly doubled over the past 25 years, there has not been a substantial …

Introduction Older adults, including racial and ethnic minorities, are underrepresented in
research. As the US population ages, the number of older racial and ethnic minority …

Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD)
disproportionally affect Hispanic and Latino populations, yet Hispanics/Latinos are …

Objectives People with psychosis delay accessing recommended treatments, resulting in
poor healthcare outcomes and increased risk of relapse. Means of improving help‐seeking …

Background Malaria and tetanus infections among pregnant women represent two major
public health problems in sub-Saharan Africa. Optimum use of Intermittent preventive …